Protonix, Pantoprazole News

WASHINGTON Drug maker Wyeth has become the subject of lawsuits accusing it of cheating Medicaid programs out of hundreds of millions of dollars.

May 14, 2009 Irreparable Harm of Generic Competition: Federal Circuit Affirms Finding that Generic Entry Does not Cause Irreparable Harm Altana Pharma & Wyeth v. Teva Altana's Patent No.

A U.S. appeals court refused on Thursday to give drugmakers Altana AG and Wyeth a preliminary injunction in a patent fight with Teva Pharmaceutical Industries over the ulcer drug Protonix.

This is Actavis' first own brand launch of this molecule. It is a proton pump inhibitor , used to treat acid-related stomach and throat problems, including acid reflux , erosive esophagitis and Zollinger-Ellison syndrome.

A new study has added to the concern that commonly used proton-pump inhibitors may interfere with Plavix in people who have coronary artery disease.

Four of the most commonly prescribed heartburn medications reduce the benefit associated with clopidogrel, a widely used antiplatelet medication also known by its brand name, Plavix.

Washington, May 7 : Scientists have found that the medicines used for the treatment of heartburn and ulcers can reduce the anti-clotting action of the medication clopidogrel, thereby resulting in about 50 per cent increase in the combined risk of hospitalisation for heart attack, stroke, and other serious cardiovascular illnesses.

Bidding for Nycomed A/S, the Swiss drugmaker put up for sale by its private-equity owners, may be limited by the companya s dearth of new medicines.

DEAR DR. DONOHUE: I am a 64-year-old woman, and I have been on Nexium for two years for heartburn.

Switzerland's Nycomed has reportedly asked Goldman Sachs to explore a possible sale of the company which could bring in as much as 10 billion euros.

March 3, 2009 -- Heart attack patients who take an acid-reducing proton pump inhibitor drug like Prilosec or Nexium in combination with the antiplatelet drug Plavix are more likely to have a second heart attack ...

In patients with gastroesophageal reflux disease , esomeprazole, has demonstrated pharmacological and clinical benefits beyond those seen with the other proton pump inhibitors .

For Nycomed the twelve months of 2008 have been satisfactory and most of the markets performed well and met expectations.

Nycomed's proton-pump inhibitor pantoprazole is set to become the second non-prescription medicine authorised through Europe's centralised procedure, following orlistat.

A study by researchers at the Institute for Clinical Evaluative Sciences in Toronto, appears to indicate that the use of clopidogrel in combination with some proton pump inhibitors can increase the risk of ...

CMAJ reports that proton pump inhibitors , which inhibit the cytochrome P450 2C19 enzyme responsible for biotransformation of clopidogrel from prodrug to active drug, cause a clinically significant interaction ...

Caraco Pharmaceutical Laboratories, Ltd. posted net sales for the third quarter ended December 31, 2008 and first nine months of Fiscal 2009 of $55.7 million and $286.2 million, respectively, as compared to ...

Patients who are prescribed popular blood-thinning drug to prevent a heart attack while at the same time take certain anti-acid medications may actually boost their risk of having a heart attack, a new study ...

Patients taking the common cardiac drug clopidogrel following a heart attack are at a significantly higher risk of a recurrence if they are also taking widely used acid-lowering medications called proton pump ...

When he came on board in 1999, the company was a small, primarily Scandinavian operation.